Subscribe to our Newsletters !!
The safety and quality of produced medicines is ex
The use of the Greek letter sigma (Σ, σ) extends
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceutica
2026 marks a new chapter for the pharmaceutical an
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-look
Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, the RIA news agency mentioned Russian customer safety watchdog Rospotrebnadzor as saying on Wednesday
The institute completed early-stage human trials, known as Phase II, earlier this month.
